Canada has an opportunity to prevent sustained Clade I mpox transmission, but only if decisive action is taken now.

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

The cumulative number of laboratory-confirmed mpox cases in Uganda has reached 4,342, with 31 deaths reported since the ...

The mpox virus is currently rampaging through the Democratic Republic of Congo, with 2,000 cases since the start of the year ...

Experts have sounded the alarm over a mutation of the mpox virus that is said to be 'highly transmissible'. The dangerous new ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an ...

Dar es Salaam. The Ministry of Health has confirmed two cases of Mpox, marking the first time the disease has been reported ...

Cases of mpox disease have increased in Uganda over the past six weeks, surpassing those of the Democratic Republic of the Congo (DRC), says the World Health Organization (WHO). In the weeks spanning ...

Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...

Countries in Africa are having to seek alternative funding amid a block to US funding for mpox response efforts.